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Background: Williams syndrome transcription factor (WSTF) is a multifaceted protein that is involved in several
nuclear processes, including replication, transcription, and the DNA damage response. WSTF participates in a
chromatin-remodeling complex with the ISWI ATPase, SNF2H, and is thought to contribute to the maintenance of
heterochromatin, including at the human inactive X chromosome (Xi). WSTF is encoded by BAZ1B, and is one of
twenty-eight genes that are hemizygously deleted in the genetic disorder Williams-Beuren syndrome (WBS).
Results: To explore the function of WSTF, we performed zinc finger nuclease-assisted targeting of the BAZ1B gene
and isolated several independent knockout clones in human cells. Our results show that, while heterochromatin at
the Xi is unaltered, new inappropriate areas of heterochromatin spontaneously form and resolve throughout the
nucleus, appearing as large DAPI-dense staining blocks, defined by histone H3 lysine-9 trimethylation and associ-
ation of the proteins heterochromatin protein 1 and structural maintenance of chromosomes flexible hinge domain
containing 1. In three independent mutants, the expression of a large number of genes were impacted, both up
and down, by WSTF loss.
Conclusions: Given the inappropriate appearance of regions of heterochromatin in BAZ1B knockout cells, it is
evident that WSTF performs a critical role in maintaining chromatin and transcriptional states, a property that is
likely compromised by WSTF haploinsufficiency in WBS patients.Background
X chromosome inactivation (XCI) is the process whereby
females balance the levels of X-linked gene expression
with males [1], and is an archetypal example of epigenetic
regulation. Much is known about the early stages of XCI,
including counting, choice, initiation, and spreading of the
inactivation signal [2], but our understanding of how chro-
matin of the chosen inactive X chromosome (Xi) and gene
silencing is faithfully maintained throughout subsequent
somatic cell divisions is less well understood.
The human Xi is primarily composed of two spatially
distinct types of heterochromatin [3]; one is character-
ized by histone H3 trimethylated at lysine 9 (H3K9me3)
[4,5] and association of heterochromatin protein 1
(HP1) [6], whereas the other is defined by histone H3* Correspondence: chadwick@bio.fsu.edu
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distribution, and reproduction in any mediumtrimethylated at lysine 27 (H3K27me3) [7,8], elevated
levels of the histone variant macroH2A [9-11], and associ-
ation of the X-inactive specific transcript (XIST) [12-14].
We have previously shown that the WSTF-ISWI chroma-
tin remodeling complex (WICH) transiently associates
with the human Xi as the chromosome is undergoing
DNA replication [15] and, therefore, is a candidate for
maintaining this chromatin organization. Current models
suggest that Williams syndrome transcription factor
(WSTF), one of two subunits in the WICH chromatin re-
modeling complex [16], assists in reforming chromatin
states of the parental cell post DNA replication [17]. Con-
sistent with this model, depletion of WSTF protein levels
by RNA-interference (RNAi) resulted in aberrant hetero-
chromatin formation [18].
WSTF is encoded by the gene BAZ1B, which is lo-
cated at 7q11.23 [GenBank: NG027679] [19]. It is ae BioMed Central Ltd. This is an open access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cesses, including transcription [20], replication [16], and
the DNA damage response [21]. In addition to the
WICH complex, WSTF has been identified as a partici-
pant in the B-WICH complex, which is associated with
transcription of the ribosomal genes [22]. WSTF is also
linked to the DNA damage response pathway, and was
recently shown to possess tyrosine kinase activity, phos-
phorylating Tyr142 of H2A.X [21]. The significance of
this covalent histone modification sits at the juncture
between deciding on DNA repair or apoptosis [23] based
on whether the modification is removed to allow access
to the MDC1 complex or retained resulting in activation
of the JNK pathway [24].
Interestingly, WSTF is deficient in Williams-Beuren syn-
drome (WBS; OMIM#194050), an autosomal dominant
genetic disorder that affects approximately 1 in 7,500 indi-
viduals [25]. The disorder is characterized by a 1.5-1.8
megabase (Mb) deletion from one copy of chromosome
7q11.23 [26]. The deletion arises de novo, due to low-copy
repeat elements flanking either side of the break points
[27], and comprises approximately twenty-eight genes
[28-31]. WBS patients experience an array of symptoms
including cardiac defects, cognitive impairment, hypercal-
caemia, growth deficiencies, and a distinct craniofacial
phenotype [32-34]. Stemming from studies performed in
mouse and cell lines, WSTF has been implicated as a key
contributor to many of the phenotypes seen in WBS pa-
tients, despite the number of other genes that are also de-
ficient [16,35,36]. It is unclear, however, which specific
gene deficiencies contribute to each symptom; a problem
common to all contiguous gene deletion disorders.
The aim of this study was to investigate the impact of
WSTF loss on the maintenance of chromatin at the hu-
man Xi, and more broadly, to develop a better under-
standing of how the loss of this multifaceted protein
affects general cellular processes. Towards this goal, we
disrupted the BAZ1B gene using zinc-finger nuclease-
assisted gene targeting in the cell line hTERT-RPE1
(RPE1)—a telomerase immortalized [37], diploid female
cell line—and isolated several independent clones that
lack the WSTF protein. Findings from this study under-
score the necessity of determining the role of WSTF,
particularly in regards to chromatin maintenance.
Results
Disruption of the BAZ1B gene using zinc finger nuclease
technology
The development of zinc finger nuclease technology
provides opportunities for genomic editing at precise lo-
cations in human cells [38]. Here, we introduced into
RPE1 cells a pair of zinc finger nucleases (ZFNs) de-
signed to exon-7 of the BAZ1B gene, along with an engi-
neered repair template (Figure 1a). The repair templateconsisted of a central promoterless neomycin open read-
ing frame (ORF) that was preceded by a splice acceptor
and internal ribosome entry site, and followed by a poly-
adenylation signal [39]. This central cassette was flanked
by homology arms (HA) of approximately 600–800 bp
that were derived from sequences in the vicinity of
exon-7 (Figure 1a). The general strategy is that upon
generation of a double-stranded break by the ZFNs, the
repair template is used though homology mediated re-
pair to patch the damage, introducing the neomycin
ORF in place of exon-7 in the process. This synthetic
exon promoter trap (SEPT) is incorporated into the tar-
geted BAZ1B transcript, prematurely truncating the
message through poly-adenylation and providing neomy-
cin resistance, driven by the gene’s own expression.
Transfected cells were placed under neomycin selection,
and after two weeks clones emerged.
Screening for correct targeting was achieved by per-
forming PCR for both the left and right sides of the tar-
geted region with a primer within the SEPT cassette and
a primer located outside of the HAs at the genomic
locus (Figure 1b). We screened a total of 119 single cell
clones by PCR. We identified 13 clones that were cor-
rectly targeted at one or both alleles of the BAZ1B gene.
To screen for targeting at both alleles, a second PCR
was performed with primers flanking the ZFN target site
(Figure 1a). If a clone was targeted at both alleles, this
sequence would no longer be present and no product
would be detected. Three clones were determined to be
successfully targeted at both alleles. Double-strand
breaks generated by ZFNs can be repaired by either
homology mediated repair or non-homologous end join-
ing (NHEJ). NHEJ is not a precise repair pathway, fre-
quently resulting in introduction of small insertions or
deletions at the target site [40], which can disrupt the
reading frame of the target gene. For those clones that
were targeted at only one allele, we screened for NHEJ
at the second allele by sequencing the PCR product. We
identified three clones that were targeted at one allele
and have the second allele disrupted by NHEJ (Figure 1c),
and several clones that were targeted at one allele but
wild-type at the second allele. This latter group of het-
erozygous mutant clones are useful models to investigate
the contribution of BAZ1B hemizygosity in WBS in the
absence of the other >20 genes that are typically lost
alongside BAZ1B in this disease, all of which potentially
contribute to the phenotype. The clones used in this
study and the nature of their mutation/s is indicated in
Table 1.
Quantitative real time PCR (qRT-PCR) using primers
that spanned exons-2 and −3 indicated that a clone tar-
geted at only one allele (Clone A6), showed BAZ1B
mRNA at 47.6% of parental cells. Clone M1, targeted at
one allele and mutated at the second by NHEJ, expressed
Figure 1 (See legend on next page.)
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Figure 1 Generation of BAZ1B knockout cells. (a) Schematic representation of the BAZ1B gene. Exons: numbered vertical bars. Introns:
connecting lines. Exon 7 is bracketed by the blue lines, and expanded beneath. The targeting construct is shown beneath, indicating the location
of the neomycin resistance gene and the extent of the homology arms (regions between the vertical dotted lines). Left and right side screening
PCRs are indicated below by inward-facing arrowheads. The NHEJ PCR is shown above Exon 7, and the ZFN cutting site is indicated by the white
arrowheads within the exon. (b) Example of an ethidium bromide stained gel showing a positive clone by PCR. (c) DNA sequence alignment of
parental RPE1 with NHEJ disrupted clones. The cutting site for the ZFNs is highlighted in red. Deletions in NHEJ clones are indicated by the red
gaps; insertions by the blue triangle. (d) qRT-PCR analysis of BAZ1B showing levels in a heterozygous mutant (BAZ1B +/−), a clone with one allele
targeted and one disrupted by NHEJ (BAZ1B -/NHEJ) and a clone targeted at both alleles (BAZ1B −/−) relative to parental RPE1. (e) Indirect im-
munofluorescence showing the distribution of WSTF in RPE1, a BAZ1B +/−, BAZ1B -/NHEJ and a BAZ1B −/− clone. WSTF is shown in green for the
Bethyl Labs anti-WSTF antibody and red for the Cell Signaling anti-WSTF antibody. The white arrowheads indicate the location of the Xi. The nu-
cleus is counterstained with DAPI (blue). (f) Western blot for WSTF with the Cell Signaling antibody in RPE1, a BAZ1B +/−, and various independ-
ent BAZ1B knockout mutants. Actin is shown immediately below. (g) Schematic map of WSTF showing the relative location of functional
domains, and the truncated proteins possible in the different mutant types. (h) Western blot using the Bethyl Labs anti-WSTF antibody as
described for part-f above.
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geted at both alleles, showed 33.7% (Figure 1d). Expression
of BAZ1B is expected as exons 1–6 are uninterrupted and
isolation of clones required BAZ1B expression to trap the
SEPT cassette and express neomycin resistance. The re-
duced levels of mRNA likely represent destabilization of
the BAZ1BmRNA.
We then employed indirect immunofluorescence (IF)
to investigate the distribution of WSTF in the BAZ1B
mutants. Here, we used two independent antibodies
raised to different regions of the WSTF protein; one to
the first 50 amino acids, and the other to a peptide at
the carboxy terminus. Results indicate that WSTF distri-
bution in the BAZ1B heterozygous mutant was very
similar to that of the parental cells, whereas WSTF
staining was absent in all double-targeted clones sug-
gesting a complete knockout of the gene (Figure 1e). To
confirm loss of WSTF, Western blotting was performed
on protein extracts from the mutants. Consistent with
the IF analysis, protein levels were reduced in the het-
erozygous mutant and absent from all independent
homozygous mutant clones (Figure 1f ). By targeting
exon-7, the ORF contained within the first 6 exons could
potentially generate a truncated protein of 87.3 kDa
(from NHEJ targeted alleles, amino acids 1–761) or
34.5 kDa (from double targeted alleles, amino acids 1–Table 1 BAZ1B mutations in clones used in this study
Clone BAZ1B Allele 1 BAZ1B Allele 2
BAZ1B-A6 (+/−) Promoter trap targeted Wild type
BAZ1B-D5 (−/−) Promoter trap targeted Promoter trap targeted
BAZ1B-F3 (−/−) Promoter trap targeted Promoter trap targeted
BAZ1B-M1 (−/−) Promoter trap targeted 16 bp deletion
BAZ1B-N6 (−/−) Promoter trap targeted 2 bp deletion
BAZ1B-O4 (−/−) Promoter trap targeted 4 bp insertion
Table indicates the nature of the mutations generated at the two
chromosome 7 BAZ1B alleles for the clones used in this study. Next to each
clone name, (+/−) indicates heterozygous mutant whereas (−/−) indicates
homozygous mutant.297) (Figure 1g). The NHEJ form would contain the
WAC and DDT domains only, whereas the double tar-
geted form of the protein would only contain the WAC
domain. In order to detect such a protein, we repeated
the Western analysis using the second antibody that was
raised to the first 50 amino acids of WSTF. Consistent
with the first Western, no truncated protein could be
detected (Figure 1h).
Loss of WSTF does not impact chromatin of the human Xi
At interphase, the Xi can be readily detected as a densely
staining heterochromatin mass, or Barr body, that is typic-
ally located in a perinucleolar or peripheral location in the
nucleus [41]. The Xi is painted by XIST RNA [14] and fac-
ultative heterochromatin markers are readily observed due
to the chromosome wide silencing, resulting in an un-
usually large concentration of these features. Previously,
we have shown that WSTF as part of the WICH complex,
associates with the Xi territory during S-phase [15] as the
chromosome is replicated [42]. In order to determine if
WSTF loss impacts the organization and maintenance of
Xi chromatin, we assessed a number of Xi markers for
changes in their distribution.
First, we performed RNA FISH to investigate whether
the Xi had retained its association with XIST RNA.
Here, we found that XIST RNA was enriched in the
vicinity of the Barr body in BAZ1B knockouts in a pat-
tern indistinguishable from that of parental RPE1 cells
(Figure 2a). Next, we examined other chromatin features
of the Xi. Typical characteristics of the human Xi in-
clude an enrichment of H3K9me3 [4,5], H3K27me3
[7,8], and mH2A1 [10], and a noticeable absence of
H3K4me2 [4,43] and histone acetylation [44], such as
H3K9Ac. By IF, none of these features appeared per-
turbed in the BAZ1B knockouts, having distribution pat-
terns indistinguishable from that observed in parental
RPE1 cells (Figure 2b). However, of note, the distribution
of H3K9me3 throughout the rest of the nucleus ap-
peared more punctate (Figure 2b, top row).
Figure 2 Investigating the impact of WSTF loss on the human
Xi. (a) Distribution of XIST RNA in RPE1 and BAZ1B −/− using a
direct-labeled RNA FISH probe (green). Nuclei in all images are coun-
terstained with DAPI (blue), merged images are shown on the right
of each group of three images, and white arrowheads indicate the
location of the Xi. (b) Examples of the distribution of markers that
are elevated at the Xi territory including H3K9me3 (green),
H3K27me3 (green) and mH2A1 (red), and those that are underrepre-
sented; H3K4me2 (green) and H3K9Ac (green). (c) Examples of ele-
vated levels of BRCA1, γ-H2A.X and SNF2H at the Xi (red). SNF2H
was never observed enriched at the Xi BAZ1B −/−.
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ciate with the Xi during S-phase [15]. Other transient
features of the Xi during this time include the associ-
ation of the breast cancer gene (BRCA1) and the phos-
phorylation of histone H2A.X at serine 139 (γ-H2A.X)[45]. We sought to determine if these features were al-
tered in the BAZ1B knockout cells. Towards this aim, we
employed IF using antibodies to BRCA1, γ-H2A.X, and
SNF2H—WSTF’s partner in the WICH complex [16]. We
found that BRCA1 and γ-H2A.X still localize to the Xi
(1.5% and 2.5% respectively, n = 200) (Figure 2c), similar
to what is reported in the parental cells [15,45]. In con-
trast, SNF2H was no longer detected at elevated levels at
the Xi (n = 1242). However, SNF2H protein still exhibited
diffuse staining at other locations within the nucleus, con-
sistent with its role in other complexes independent of
WSTF and WICH [46-49].
Cells lacking WSTF exhibit a unique nuclear phenotype
DNA staining with 4′,6-diamidino-2-phenylindole (DAPI)
revealed a nuclear phenotype unique to BAZ1B knockout
cells. In parental hTERT-RPE1 nuclei, the most intense
DAPI staining structure corresponds to the Barr body, as
indicated by the white arrow in Figure 3a. In contrast, the
nuclei of BAZ1B knockout cells show additional DAPI
dense bodies of comparable to greater intensity as demon-
strated by the pixel saturation in Figure 3b and 3c. Not all
nuclei show the appearance of these structures. We ob-
served that 23.21% of nuclei (n = 2356) possessed numer-
ous large DAPI-dense regions (Figure 3d). Intriguingly,
transient reduction of either component of the WICH
complex by RNAi was reported to result in a gain of het-
erochromatin [18], consistent with these observations.
We sought to further characterize both the compos-
ition and dynamics of the DAPI–dense regions, as the
appearance of blocks in only a subset of cells raised the
possibility that the blocks could be linked to a cell cycle,
arrest in proliferation, or potentially early stages of cell
death.
DAPI-dense regions are enriched for constitutive
heterochromatin markers
Areas of intense DAPI staining in nuclei typically corres-
pond to regions of heterochromatin, such as the consti-
tutive heterochromatin of mouse major satellite [50],
senescence associated heterochromatin blocks [51], or
facultative heterochromatin of the Xi [14]. The blocks
seen in the BAZ1B homozygous mutants were reminis-
cent of the heterochromatic Barr body in both DAPI in-
tensity and size. For this reason, we examined the blocks
for association with heterochromatic features and vari-
ous complexes known to interact with heterochromatin.
To accomplish this, we pursued several avenues of in-
vestigation. First, we explored the relationship of the
blocks with the three different HP1 proteins: HP1α,
HP1β, and HP1γ [52-54]. Chromatin associated HP1
levels were shown previously to increase in cells with de-
pleted levels of WSTF, particularly HP1β [18]. Consist-
ent with this observation, we found that all three HP1
Figure 3 BAZ1B homozygous knockout cells exhibit a unique nuclear phenotype. Representative images of RPE1 (a), BAZ1B-N6 (b) and
BAZ1B-O4 (c) nuclei counterstained with DAPI. White arrow-heads in (b) and (c) point to block-containing nuclei. White arrows point to the DAPI-
dense Barr body. Images were captured using settings defined for RPE1 that result in pixel saturation for block-containing BAZ1B −/− nuclei. (d) RPE1
and BAZ1B −/− nuclei stained with DAPI showing the appearance of large DAPI-dense blocks in a fraction of mutant cells, as indicated to the left.
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To validate that all three isoforms did indeed associate
with the blocks and that this was not a by-product of
antibody cross-reactivity, we transiently transfected
BAZ1B knockout cells with HP1α, HP1β, or HP1γ green
fluorescent protein (GFP) expression constructs. We
found that all three exogenous HP1 types, with HP1α to
a lesser extent, localized to the blocks (Figure 4b).
Next, we continued to characterize the DAPI-dense
blocks in the BAZ1B knockouts through IF to a variety
of heterochromatin-associated proteins and covalent his-
tone modifications. Our results showed that, consistent
with binding of HP1 to H3K9me3 [55-57], the blocks
were clearly defined by this modification (Figure 4c).
Given the size of the blocks, we wondered if this rep-
resented an overall increase in H3K9me3 levels. His-
tones were extracted from parental and WSTF mutant
cells and H3K9me3 levels detected by Western blotting.
Despite the apparent increase by IF, H3K9me3 levels
were comparable between mutants and parental cells(Figure 4d). However, given that only 23% of cells show
blocks, it is possible that increases are masked by the
77% of normal cells.
Recently, the structural maintenance of heterochroma-
tin protein, SMCHD1, was linked to HP1 and H3K9me3
[58]. In agreement with this, SMCHD1 associated with
the DAPI blocks (Figure 4e). With the exception of the
Xi, comparable large blocks of HP1α, HP1β, HP1γ,
H3K9me3 and SMCHD1 were not a feature of parental
cells (Additional file 1).
Although they did not completely colocalize, areas of
MBD1 and HMG-I/Y enrichment were present within
portions of the blocks (Additional file 1). As expected,
the blocks had no association with euchromatin markers
(Figure 4f ). However, 14 other heterochromatin proteins
did not associate with the blocks, including TIF1B,
EZH2, Mi2, RbAp46, RbAp48, SAP18, SAP30, SIN3A,
SIN3B, HDAC1, HDAC2, MBD3, ATRX, and SETDB1,
nor histone H1 or the histone variant macroH2A1
(Additional file 1).
Figure 4 BAZ1B −/− DAPI-dense blocks are characterized by constitutive heterochromatin markers. (a) Association of endogenous HP1α,
HP1β, and HP1γ (green) with DAPI-dense blocks. Nuclei are counterstained with DAPI (blue) and merged images are shown in the right-side
panel. (b) Association of exogenous GFP-tagged HP1α, HP1β, and HP1γ (green) with DAPI-dense blocks. (c) Examples of elevated levels of
H3K9me3 (green) at DAPI-dense blocks. (d) Western blot showing comparable levels of H3K9me3 in mutant compared to RPE1. Anti-histone H4
is used as a loading control. (e) Example of the association of SMCHD1 (green) with DAPI-dense blocks. (f) Examples showing the lack of associ-
ation of euchromatin markers H3K4me2 and H3K9Ac with the DAPI-dense blocks.
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structures
We sought to determine if the DAPI-dense regions were
associated with disruption of B-WICH activity, due to its
participation in ribosomal DNA transcription at nucleoli
[20]. The nucleolar organizing region (NOR) of the acro-
centric chromosomes (13, 14, 15, 21, and 22) localizes to
and can be used to define the extent of nucleoli [15].
We performed DNA FISH using a BAC from the NORas a probe, and IF using an antibody raised against
MYBBP1A, a member of the B-WICH complex [20], to
examine if the DAPI blocks coincided with nucleoli. We
found that neither NOR or MYBBP1A overlapped with
the DAPI-dense blocks (Figure 5a).
Given the large number of DAPI-dense blocks, we
wondered if they corresponded to the inappropriate
spread of centromeric heterochromatin. The reasoning
behind this assumption is that cells treated with RNAi
Figure 5 BAZ1B −/− DAPI-dense block relationship to other nu-
clear structures. (a) DAPI-dense block distribution relative to nucle-
oli markers MYBBP1A (red, IF) and NOR (red, direct-labeled FISH). (b)
DAPI-dense block distribution relative to centromere markers CENP-
A (green, IF) and alpha-satellite DNA indicated by a pan-centromeric
direct-labeled FISH probe (green). (c) DAPI-dense block distribution
relative to PML bodies (green, IF).
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tulated to represent gain of heterochromatin [18], and
that HP1 is a feature of centromeric heterochromatin
[59]. We addressed this two ways, first by DNA FISH
with a pan-centromeric probe, and second by IF to the
centromeric protein CENP-A [60,61]. We found that the
blocks did not overlap with either centromeric DNA or
CENP-A-positive regions (Figure 5b), although signals
often resided at the edge of the blocks.
Prior studies have also linked WSTF function to sev-
eral cellular processes including DNA replication(WICH), transcription (B-WICH), and epigenetic silen-
cing (WICH) [62]. Like WSTF, promyelocytic leukemia
(PML) bodies have also been linked to the processes of
DNA replication, transcription, and epigenetic silencing
[63]. In addition, the number, and sometimes size, of
PML bodies are reminiscent of the DAPI-dense blocks
that we see in BAZ1B knockout cells. Altogether, this
led us to question whether the DAPI-dense blocks were
expanded PML bodies. To test this question, we de-
tected PML bodies by IF. We found that PML bodies
had not increased in size and did not colocalize with the
DAPI-dense blocks (Figure 5c).
DAPI-dense blocks in BAZ1B knockout cells are not linked
to and do not disrupt the cell cycle
The appearance of the DAPI-dense blocks in only a sub-
set of cells could be explained by their appearance being
associated with a particular period during the cell cycle.
In order to test this, we examined cells labeled with
markers of the cell cycle: CDT1 for G1 [64,65], PCNA
distribution for S-phase [66,67], and phosphorylation of
histone H3 at serine 10 (H3S10ph) for G2 phase [68].
DAPI-dense blocks were detected at all stages of the cell
cycle (Figure 6a).
Next, we wondered if the appearance of these blocks
affected the progression of the cell cycle. However, cell
cycle profiles determined by fluorescence activated cell
sorting (FACS) were indistinguishable between parental
RPE1 and BAZ1B knockout cells (Figure 6b).
These observations suggest that perhaps cells were
slowly acquiring blocks over time, or that only a subset
of cells always have blocks and others do not.
Cells containing DAPI-dense blocks do not accumulate
over time in culture and are not stably inherited
In order to determine if the number of cells with DAPI-
dense blocks was accumulating over time, we monitored
cells for the percentage of DAPI-dense positive nuclei
every 10 passage doublings for a total of 70 doublings.
We found that at any given passage doubling, the popu-
lation of cells with DAPI-dense blocks remained consist-
ently around 20-25% of cells (Table 2).
Since only a subset of cells possessed the DAPI blocks,
we questioned whether they were a stable heritable trait
that could be passed on to daughter cells. If this were
the case, we would expect that clones derived from a
non DAPI-dense block containing cell would show no
blocks, while those derived from a DAPI-dense block
containing cell would all contain blocks. To investigate
this question, we isolated single cell clones and exam-
ined eight subclones of each of three independent
BAZ1B homozygous knockout mutants for the presence
or absence of the DAPI-dense blocks. Interestingly, all
subclones contained cells with and without DAPI-dense
Figure 6 DAPI-dense blocks in BAZ1B −/− are present in G1, S and G2 phase and do not disrupt the cell cycle. (a) Examples of DAPI-dense
blocks in BAZ1B −/− cells at different stages of the cell cycle as indicated by the appropriate markers; CDT1 for G1 (green, top), PCNA for S-phase (red,
middle) and H3S10ph for G2 (green, bottom). H3S10ph accumulates first at heterochromatic regions before spreading throughout the nucleus [68],
accounting for the elevated levels observed at the heterochromatin blocks in the example shown. The percentages given in brackets to the left of the DAPI
image indicate the number of cells positive for the cell cycle stage marker in the population of cells examined (CTD1, n = 83; PCNA, n = 105; H3S10ph,
n = 115). Note that the numbers are greater than 100%. This is because some H3S10ph positive cells are in late S-phase in RPE1 [15], and CDT1, while
present throughout the cell cycle, is most abundant during G1 [64]. Consequently some cells from other stages of the cell cycle are inadvertently included
in these numbers. (b) Representative FACS profile for RPE1 and BAZ1B −/−.
















Table shows the percentage of BAZ1B −/− clone D5 nuclei that showed DAPI-
dense blocks over the course of 70 passage doublings. A total of 2356 nuclei
were scored. The mean and standard deviation is 23.73% +/−3.56.
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velop and resolve blocks regardless of the state of the
parent cell. However, it remains a possibility that those
cells acquiring blocks arrest in the cell cycle and eventu-
ally die.
DAPI-dense blocks are dynamic
The transient transfection of HP1β into BAZ1B knockout




Percentage of nuclei with DAPI-dense
blocks for 8 independent subclones
Mean & standard
deviation
D5 78, 50, 76, 78, 44, 58, 40, 48 59.0% +/− 16.0
F3 8, 40, 22, 56, 24, 42, 20, 24 29.5% +/− 14.0
M1 20, 28, 20, 18, 22, 20, 32, 38 24.8% +/− 7.0
Table shows the percentage of nuclei with DAPI-dense blocks for each of eight
single-cell subclones derived from three independent BAZ1B −/− clones. Fifty
nuclei were scored for each subclone.
Figure 7 Distribution of exogenous Myc-tagged WSTF in BAZ1B
−/− nuclei. (a) Distribution of exogenous WSTF as detected by anti-
WSTF IF in BAZ1B −/− nuclei (green) (top row) and the MYC-tag (red)
(bottom row). Examples of elevated levels at the Xi are indicated with
the white arrowheads. (b) Elevated levels of exogenous WSTF-Myc
(red) at the Xi as defined by H3K27me3 (green). The location of the Xi
is indicated by the white arrowhead. Nuclei are counterstained with
DAPI (blue).
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the GFP construct in real time. Cells expressing HP1β-
GFP were followed over 24 hour and 72 hour periods.
Since the number of block-containing cells did not in-
crease in the population over time, the blocks could either
be spontaneously forming and resolving, or those cells
with blocks could arrest, or undergo apoptosis. We ob-
served that the block-containing nuclei did not undergo
apoptosis, but were readily able to divide, ruling out arrest
in the cell cycle (See Additional file 2). We found that a
block-containing cell was able to give rise to a daughter
cell that also acquired blocks, and, therefore, the condition
was mitotically heritable (Additional file 3). Furthermore,
the blocks appear to resolve with the exception of the Xi-
associated HP1β-GFP block, highlighting the dynamic na-
ture of the blocks. Interestingly, we noted that, despite
substantial movement by the cell body, the blocks were
static within nuclei (Additional file 4), similar to observa-
tions made in real-time with replication factories [67]. Fi-
nally, blocks were observed for as long as 24 hours in cells
before dividing, and appeared to resolve right before enter-
ing mitosis, confirming that they are not transient features
of a particular cell cycle stage (Additional file 3). Given
these observations and the fact that single cell clones give
rise to a similar fraction of cells with DAPI-dense blocks
as the parental cell population (and not 100% block-
containing or 100% block-free), we conclude that the ap-
pearance and resolving of the blocks is a dynamic process.
What triggers the formation and subsequent resolution of
the blocks in some cells and not others is presently
unknown.
Introduction of exogenous full length WSTF ORF is
sufficient to remove the appearance of DAPI-dense blocks
We wondered if the DAPI-dense blocks in BAZ1B
knockout cells could be removed by reintroducing wild
type WSTF protein. To test this, an expression construct
containing a Myc-tagged full-length WSTF ORF was in-
troduced into WSTF knockout cells by Nucleofection.
Cells were examined by IF using antibodies specific to
the Myc-tag and WSTF. Cells that were positive for Myc
were also positive for WSTF (n = 94) (Figure 7a). Fur-
thermore, transfected cells were restored for transient
association of WSTF to the Xi as defined by H3K27me3
[15] (Figure 7b). We examined Myc-positive nuclei for
DAPI-dense blocks. All Myc-positive nuclei showed
DAPI patterns comparable to parental RPE1, with no
evidence of intense DAPI-dense blocks (n = 119), sug-
gesting that the blocks can be resolved by reintroduction
of wild-type protein.
Loss of WSTF results in gene expression changes
Given that the DAPI-dense blocks are enriched for
markers of constitutive heterochromatin, and that WSTFis involved in transcription [62], we assessed the WSTF
mutant cells for changes in gene expression, with the
thought that perhaps most gene expression changes
would be reductions due to the gain in heterochromatin.
Total RNA was extracted from three separate cultures of
parental RPE1 cells as well as from three separate cul-
tures for each of three independent BAZ1B knockout
clones, and one heterozygous mutant clone. Residual
DNA in the RNA preparation was digested and its re-
moval confirmed by PCR before preparing cDNA, label-
ing and hybridizing to a NimbleGen human gene
expression 12x135K array containing >45,000 transcript
targets. Genes that had significant changes of two fold
or more compared to RPE1 (p < 0.05) were identified for
each mutant. The heat map shown in Figure 8a, clearly
shows consistent and substantial changes in gene ex-
pression between the three independent BAZ1B mutants
as compared to the parental RPE1 cells. The genes that
were not shared between all three independent mutants
were excluded. The remaining genes of interest can be
found in Additional file 5 (n = 515). In the knockout
cells, genes for which expression levels changed were
not all reductions; some went up (173) while others
went down (342). To validate the microarray data, we
performed quantitative RT-PCR (qRT-PCR) on several
genes that showed increases or decreases in the micro-
array data relative to the parental RPE1 cells. All
Figure 8 Gene expression changes in BAZ1B −/− cells. (a)
Dendrogram (Heat Map) of hierarchical clustering of gene expression
between RPE1 and three independent BAZ1B −/− clones. Heat map
represents 586 data points, corresponding to probes showing greater
than 2-fold change in gene expression at 95% confidence. Expression
levels range from +1.4 to +14.2, corresponding to signal intensity on the
microarray and represented by a blue (low) to red (high) gradation indi-
cated by the scale bar beneath the heat map. Each column represents
the averaged signal from three replicate data sets for each clone. Each
row represents a single specific probe. Changes in gene expression can
be seen by the difference in row colors between the mutants and paren-
tal cells. (b) Representative examples of genes activated in BAZ1B −/−
cells by standard end-point RT-PCR analysis shown as an inverted image
of an ethidium bromide stained agarose gel. The gene name is given to
the left, and the cell line indicated at the top. Lanes show with (+RT) and
without (−RT) reverse transcriptase and a water control (H2O).
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Interestingly, of the 515 gene expression changes ob-
served in the BAZ1B knockouts, 72 of these were shared
in the heterozygous mutant cells (Additional file 6). Thisindicates a degree of sensitivity to WSTF haploinsuffi-
ciency, further supporting an important contributing
role of BAZ1B hemizygosity in WBS.
Despite our supposition that most genes would be si-
lenced due to the gain in heterochromatin, as mentioned
above, a substantial number of genes showed increased
expression in the mutants relative to the parental cells.
Among these, a subset appeared to show activation in
both BAZ1B −/− and BAZ1B +/− cells (Figure 8b).
These genes could not be assessed by qRT-PCR, as fold
change cannot be determined when expression of a con-
trol or unknown sample is zero, but the endpoint RT-
PCR analysis is consistent with the microarray data.
Gene expression changes were not restricted to certain
chromosomes or chromosomal regions (Additional file 5).
With the exception of chromosome 21, all chromo-
somes have genes that showed increases or decreases in
expression, although all changes were less than 2.0% of
the total gene content for the chromosome (coding and
non-coding). Given that chromosome 21 has the lowest
gene content, it does not seem that this chromosome is
an exception for any biological reason. Despite the
blocks frequently residing close to nucleoli, the NOR-
containing chromosomes (13, 14, 15, 21 and 22) did not
have the highest number of silenced genes. Instead,
the chromosomes that contained the largest number of
silenced genes were chromosomes 20 (1.55%) and 12
(1.50%). No obvious trend was observed for silenced
genes concerning genomic location, such as residing
close to large satellite blocks or in pericentromeric or
subtelomeric regions. Interestingly, the protocadherin
cluster on chromosome 5q31.3 that is associated with
various neuropsychiatric disorders [69], and implicated in
tumor suppressor activity [70,71], consistently showed an
increase in expression of most of the alpha members, but
decreases in the adjacent beta and gamma clusters. Intri-
guingly, in the heterozygous BAZ1B mutant, the alpha
cluster was up-regulated, similar to the complete knock-
out, but changes to the beta and gamma clusters were not
observed.
Discussion
Gene silencing at the Xi is remarkably stable, involving
multiple redundant gene silencing mechanisms that en-
sure silencing is maintained throughout all subsequent
somatic cell divisions. Stability of the imprinted Xi in ex-
traembryonic material is compromised upon loss of the
Polycomb group protein Embryonic Ectoderm Develop-
ment (EED) [72,73], but there are few other examples of
Xi instability due to a single gene loss. In fact, global re-
activation of the Xi has only been achieved through fu-
sion of female mammalian cells with mouse embryonal
carcinoma cells [74-77] or via reprogramming mouse fe-
male cells to pluripotency through forced expression of
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in maintaining chromatin states at the Xi, it is not sur-
prising that the loss of WSTF did not result in an obvi-
ous wave of X-linked gene reactivation and loss of
bonafide Xi markers, such as XIST or H3K27me3. Genes
that are reactivated from the Xi are unlikely to be
expressed at levels dramatically different from their Xa
counterpart. Consequently, the anticipated change in
gene expression would likely be less than two fold. How-
ever, reassessing the data for 1.5 fold change did not
show a bias toward increase in X-linked gene expression
levels compared to the autosomes (data not shown). Al-
ternatively, however, these observations can be inter-
preted to suggest that perhaps the transient association
of WSTF with the chromosome, as the Xi DNA is repli-
cated [15], is unrelated to maintenance of XCI.
WSTF, as part of the WICH complex, has been shown
to transiently associate with the Xi prior to γ-H2A.X and
BRCA1 [15]. The fact that BRCA1 and γ-H2A.X continue
to transiently associate with the Xi when WSTF is absent
suggests that the two cell-cycle linked events are not
coupled. Indeed, we have previously speculated that
WICH may transiently associate with the newly replicated
DNA in order to reestablish the basal state of H2A.X-
Y142ph. This theory supports the idea that WSTF recruit-
ment to the Xi is independent of γ-H2A.X and BRCA1 as-
sociation since the ground state of H2A.X-Y142ph is set
independently of DNA damage [21].
Intriguingly, almost one quarter of BAZ1B knockout
cells displayed numerous, large, DAPI-dense blocks. Con-
sistent with the DAPI staining, the blocks are character-
ized by constitutive heterochromatin-associated proteins,
including HP1, HMG-I/Y, and MBD1, and by the covalent
histone modification H3K9me3. In addition, the HP1-
interacting protein SMCHD1 [58], was also seen localizing
to the blocks. While the blocks did not overlap with nucle-
oli, they were often seen abutting these nuclear structures,
as indicated by NOR DNA FISH and MYBBP1A IF;
markers of nucleoli [15]. Prior studies have shown that, in
addition to rDNA-containing regions of the acrocentric
chromosomes, heterochromatin domains of most human
chromosomes (including regions found at telomeres, cen-
tromeres, and chromosome arms), associated with nucle-
oli [79]. Perhaps, perinucleolar regions are sites of
heterochromatin maintenance. Indeed, in mouse, the
binding partner of Wstf, Snf2h, transiently accumulates in
a perinucleolar region as the mouse Xi is replicated [80].
Perhaps, in BAZ1B knockout cells, checks on heterochro-
matin formation are compromised resulting in the in-
appropriate spread into genomic regions not normally
associated with heterochromatin. The obvious gain in the
large blocks of heterochromatin support a model in which
WSTF assists in maintaining chromatin states, and in its
absence, too much heterochromatin forms [17].The size and number of DAPI-dense blocks in BAZ1B
knockout cells indicates that the gain of heterochroma-
tin in affected cells is substantial. Previously, it was
shown that artificially reducing WSTF protein levels by
RNA interference, was associated with lower levels of
transcription, as measured by monitoring the levels of
bromouridine incorporation into RNA [18]. By micro-
array analysis, a large number of genes consistently
showed a reduction in expression (342) in three inde-
pendent mutants. This change could be attributed to the
gain in heterochromatin, although secondary effects,
such as silencing of a key transcription factor, cannot be
ruled out. Of interest, the reduced expression was not
global, impacting only a subset of all genes. This sug-
gests that if WSTF is acting to reestablish appropriate
chromatin states post DNA replication, as postulated
[17], it is either only acting at specific regions of the gen-
ome, as most genes are unaffected by the proteins loss,
or that certain regions of the genome are more vulner-
able to inappropriate heterochromatin spread/assembly
than others.
We also observed a large number of genes that
showed an increase in expression (173) in all three
BAZ1B knockout clones. This is consistent with WSTF’s
previously established role as a regulator of transcrip-
tion, capable of activating or silencing genes [62]. Not-
ably, loss of a single BAZ1B allele was sufficient to
impact a subset of those genes affected in the knockouts,
indicating that some genes are more sensitive to WSTF
levels than others. This has important implications for
BAZ1B hemizygosity in WBS, and our heterozygous tar-
geted clones provide an important model in which to
pursue the contribution of WSTF to the phenotype in
this complex contiguous gene deletion disorder.
Some genes showed reactivation from a silent state in
the mutants. In contrast, relatively few genes showed the
opposite trend of complete silencing in the mutants. It is
possible that within the pool of cells assessed, complete
silencing might only be observed in cells with DAPI-
dense blocks that represent fewer than 25% of the total
cell population. In these cells, genes embedded in the
blocks or within their vicinity might be fully silenced;
yet not in the 75% of cells that appear normal. Continu-
ing with this notion, it is possible that the actual number
of genes impacted by WSTF loss might be greater than
our microarray data would otherwise suggest. If some
genes show increases or decreases in gene expression
that are close to, but greater than, our 2-fold cutoff only
in DAPI-dense block nuclei, these changes might be re-
duced to below the cutoff by a lack of change in the ma-
jority non-DAPI-dense block cells.
Despite the extensive size of the DAPI blocks, we did
not see an increase in nuclear levels of H3K9me3.
Therefore, an alternative explanation for the reactivation
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redistributed to the blocks, essentially reducing local re-
pressive effects elsewhere.
The dynamic nature of the blocks is intriguing. Cells
that acquire blocks do not undergo apoptosis and the
cell cycle is apparently unaffected. Single cell cloning in-
dicates that block formation is reversible, and that the
overall number of cells with blocks remains relatively
constant within an actively dividing population and be-
tween independent mutants. Live cell imaging confirms
that block appearance is not linked to the cell cycle, and
indicates that blocks are essentially immobile, and do
not prevent cells from proceeding through mitosis. Re-
introduction of wild-type WSTF resolves the blocks, and
therefore provides a powerful manipulable system in
which to investigate regions of the WSTF protein that
are required for this activity.
Conclusions
In this study, we have explored the impact of WSTF
loss. Our findings emphasize that many aspects of the
function of WSTF remain enigmatic. Identifying the
common characteristics of the DNA sequences in the
DAPI-dense blocks may provide clues as to how WSTF
contributes to gene regulation. It is important for future
studies to examine the mechanism of WSTF action so
that we may fully understand the role that WSTF plays
in nuclear processes and its contribution to WBS. In
addition, our heterozygous mutant cells provide a useful
model to investigate the effects of BAZ1B hemizgosity
and WSTF haploinsufficiency in the absence of the loss
of the other 27 genes seen in WBS.
Methods
Cell culture
The cell line used to generate the knockout clones was
hTERT-RPE1, a 46, XX telomerase-immortalized human ret-
inal pigment epithelial cell line (Clontech, Laboratories, Inc.,
Mountain View, CA, USA: No. C4000-1). The cells were
maintained according to the supplier’s recommendations.
Generating BAZ1B knockout cell lines
The targeting template for homology mediated repair
was generated as follows. The left homology arm (HA)
was amplified by PCR with the primers LHA-F2 and
LHA-R2 (Additional file 7) using RPE1 genomic DNA as
a template. The same was done for the right HA with
the primers RHA-F1 and RHA-R1 (Additional file 7).
The PCR products for the left and right HAs were TA
cloned into pDRIVE (Qiagen, Valencia, CA, USA). Plas-
mid DNA was harvested using the Nucleospin Plasmid
kit (Machery-Nagel, Bethlehem, PA, USA), before se-
quence verifying. The insert of the left HA was excised
from the pDRIVE vector using NotI and XbaI, and theright HA was excised using XhoI and MluI. The pSEPT
cassette was digested with XbaI and XhoI and the pBC-
KO-tk-A vector (Chadwick, manuscript in preparation)
was digested with NotI and MluI. All digests were sepa-
rated on agarose gels (Agarose Unlimited, FL, USA), and
inserts excised and purified using a Nucleospin Gel and
PCR Clean-up kit (Machery-Nagel, Bethlehem, PA,
USA). The left HA, pSEPT cassette, and right HA, were
ligated overnight at 16°C into pBC-KO-tk-A vector using
T4 DNA ligase (NEB, Ipswich, MA, USA). The ligation
was transformed into NEB-5alpha chemically competent
E. coli cells according to the supplier’s recommendations
(NEB, Ipswich, MA, USA). Plasmid DNA was prepared
using the Plasmid Plus Midi kit (Qiagen, Valencia, CA,
USA). The plasmid DNA was linearized by digestion
with AscI restriction enzyme, and gel purified. To gener-
ate BAZ1B knockout cell lines, we introduced ZFN ex-
pression constructs (Sigma-Aldrich, St. Louis, MO, USA:
Cat No. CSTZFN-1KT) and the linearized repair tem-
plate by Nucleofection (Lonza Group Ltd, Basel,
Switzerland). Twenty-four hours post-Nucleofection,
cells were seeded into four 96-well plates in media sup-
plemented with neomycin (150 μg/mL). After approxi-
mately two weeks, clones were expanded and genomic
DNA isolated using a Wizard SV 96 Genomic DNA Puri-
fication System kit (Promega, Madison, WI, USA). Cor-
rectly targeted clones were screened on the left and right
sides by PCR between a primer to the genomic locus, but
distal/proximal to the HA, and a primer located in the
pSEPT cassette. The screening pairs were Left-Screen-F2
with pSEPT-R1 and pSEPT F2 with Right-Screen-R1
(Additional file 7). Clones that generated the correct sized
PCR product using these two screening pairs were tested
for NHEJ by PCR using the primers BAZ1B Sigma-F and
BAZ1B Sigma-R (Additional file 7). If a product was gen-
erated, it was sequenced to determine if NHEJ had re-
sulted in insertions or deletions. All restriction enzymes
were obtained from NEB (Ipswich, MA, USA).
WSTF rescue
A full-length wild-type human myc-tagged WSTF expres-
sion construct was obtained from Origene (Rockville, MD,
USA: Cat.No. RC216159). The expression construct was
introduced into BAZ1B knockout cells by Nucleofection
using a 4D-Nucleofector (Lonza Group Ltd, Basel,
Switzerland) and solution SF on program EN-138 accord-
ing to the manufacturers recommendations.
Antibodies
Immunofluorescence
Rabbit anti-WSTF antibodies were obtained from Cell
Signaling Technology (Danvers, MA, USA: Cat No.
2152) and Bethyl Laboratories (Montgomery, TX, USA:
Cat No. A300-446A). Rabbit anti-SMCHD1 (Cat No.
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ies (Montgomery, TX, USA). Rabbit anti-CDT1 (Cat No.
10/2012), rabbit anti-SETDB1 (Cat No. 06/2012), rabbit
anti-CENP-A (Cat No. 2186S), mouse anti-TIF1B (Cat
No. 5868S), and mouse monoclonal antibodies to myc
(Cat No. 2276S) were purchased from Cell Signaling
Technologies (Danvers, MA, USA). Mouse monoclonal
antibodies BRCA1 (Cat No. sc-6954) were obtained from
Santa Cruz Biotech (Dallas, Texas, USA) as were goat
anti-SAP18 (Cat No. sc-8473), mouse anti-Histone H1
(sc-8030), goat anti-MBD1 (Cat No. sc-9395), goat anti-
MBD2 (Cat No. sc-12444), goat anti-MBD3 (Cat No.
sc-9402), goat anti-RbAp46 (Cat No. sc-8272), goat anti-
RbAp48 (Cat No. sc-8270), goat anti-ATRX (Cat No.
sc-10080), rabbit anti-SIN3A (Cat No. sc-994), rabbit
anti-SIN3B (Cat No. sc-768), rabbit anti-Mi2 (Cat No.
sc-1564), and rabbit anti-HMG-I/Y (Cat No. sc-1564).
Antibodies to Mouse monoclonal antibodies to
phospho-H2A.X (Serine-139) (Cat No. 05–636) and
SNF2H (Cat No. 05–698) were obtained from Millipore
(Billerica, MA, USA), as were rabbit polyclonal anti-
bodies to EZH2 (Cat No. 07–400), histone H3 trimethy-
lated at lysine-27 (Cat No. 07–449), histone H3
phosphorylated at serine 10 (Cat No. 06–570), histone
H3 dimethylated at lysine 4 (Cat No. 07–0030), histone
H3 acetylated at lysine 9 (Cat No. 06–942), and histone
H3 trimethylated at lysine 9 (Cat No. 07–523). Mouse
anti-HP1α (Cat No. MAB3584), anti-HP1β (Cat No.
MAB3448), and anti-HP1γ (Cat No. MAB3450) were
obtained from Chemicon International (EMD Millipore,
Billerica, MA, USA). Mouse anti-PML (Cat No.
ab96051) antibody was purchased from Abcam (Cam-
bridge, MA, USA). Mouse anti-MYBBP1A (Cat No.
SAB1400390) was obtained from SIGMA-Aldrich (St.
Louis, MO, USA). Rabbit anti-macroH2A.1 antibody
was described previously [81]. Alexa-Fluor® conjugated
secondary antibodies were obtained from Life Technolo-
gies Corporation (Invitrogen, Grand Island, NY, USA).
DNA and RNA FISH probes
Direct-labeled FISH probes were prepared using a Nick
Translation kit with SpectrumGreen dUTP according to
the manufacturer’s recommendations (Abbott Molecular,
Abbott Park, IL, USA). P1-artificial chromosome (PAC)
RP5-1174A5, which contains rDNA and detects the Nu-
cleolar Organizing Regions (NOR), was obtained from
Dr. P. Finelli (Finelli et al. 2012). The pan-centromeric
probe (Cat No. 1695-F-02) was purchased from Cambio
(Cambridge, UK). The XIST RNA-FISH probe was as
described previously [15].
Western blotting
The protein samples for Western blotting were prepared
by lysing approximately one million cells in RIPA bufferaccording to standard procedures [82]. Samples were sep-
arated on 4-20% acrylamide gels at 200 V. Histone sam-
ples for Western blotting were prepared according to
Abcam’s histone extraction protocol (http://www.abcam.
com/index.html?pageconfig=resource&rid=11410). Sam-
ples were separated on AnykD acrylamide gels (Biorad,
Hercules, CA, USA) at 200 V. All SDS-PAGE gels were
transferred to pre-equilibrated 0.2 μ PVDF (Biorad,
Hercules, CA, USA) using a BioRad Turbo Transfer ap-
paratus. The PVDF membranes were blocked with 5%
non-fat dry milk in 0.1% PBS-Tween 20 for 30 minutes
and washed twice in 0.1% PBS-Tween 20/1% igepal for
15 minutes each. Primary antibodies were diluted in
blocking solution and either incubated with gentle rocking
overnight at 4C (WSTF Cell Signaling Technologies and
Bethyl Laboratories antibodies) or for 1 hour at room
temperature (all other antibodies). The membranes were
washed twice as described above. The membranes were
incubated with horseradish peroxidase-conjugated (HRP)
secondary antibodies diluted in blocking solution for
1 hour at room temperature with gentle rocking. The
membranes were washed as previously described. Detec-
tion of HRP was achieved by incubating membranes with
equal volumes of ECL Solution A and Solution B (GE
Healthcare, Pittsburgh, PA, USA) for 3 minutes at room
temperature. The two WSTF antibodies described above
were used. Rabbit anti-B-Actin (Cat No. 11/2012) was
purchased from Cell Signaling Technology (Danvers, MA,
USA). The rabbit anti-H3K9me3 antibody described above
for IF analysis was used for Western analysis. Rabbit anti-
Histone 4 (Cat No. 07–108) was obtained from Millipore
(Billerica, MA, USA). HRP anti-rabbit secondary antibody
was obtained from Cell Signaling Technology (Danvers,
MA, USA: Cat No. 7074S).
DNA and RNA FISH and indirect immunofluorescence
To prepare slides for IF and FISH studies, approximately
2×105 cells were grown directly on standard microscope
slides. IF was performed as described [15]. DNA was coun-
terstained using ProLong® Gold antifade reagent sup-
plemented with 4′,6-diamidino-2-phenylindole (DAPI) (Invi-
trogen, Grand Island, NY, USA). For IF combined with DNA
FISH, IF was first performed. The FISH probes were dena-
tured in the presence of human Cot-1 DNA (Invitrogen,
Grand Island, NY, USA) at 78°C for 10 minutes followed by
30 minutes at 37°C to block repetitive sequences before ap-
plying to the slides. Slides were then treated as previously de-
scribed [15]. Antifade containing DAPI was added to the
slides, followed by a cover slip. IF combined with RNA FISH
was performed essentially as described [83].
Image acquisition
Images were collected using a DeltaVision pDV (GE
Healthcare, Pittsburgh, PA, USA). Delta Vision images
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sion, Issaquah, WA, USA) and compiled with Adobe
Photoshop CS2 (Adobe Systems, San Jose, CA, USA).
Live cell imaging videos were recorded using an Andor
Revolution Spinning Disk Laser Confocal microscope
and an Andor 897 EMCCD camera (Andor Technology
plc. Belfast, UK). Live cell imaging data was processed
using Andor iQ2 software.
HP1-GFP Expression constructs
GFP-tagged HP1-α, β and γ expression constructs were
generated by excision with EcoRI of the full ORF inserts
from previously described pcDNA3.1-CT-Myc con-
structs [84], into the EcoRI site of pcDNA3.1-CT-GFP
(Invitrogen, Grand Island, NY, USA).
Fluorescence activated cell sorting (FACS) analysis
For FACS analysis, an asynchronously growing popula-
tion of 1 × 106 cells were stained with propidium iodide
[85] and flow sorted using a FACSCanto (BD Bioscience,
San Jose, CA, USA). Cell cycle profiles were generated
using FACSCanto software.
Microarray gene expression analysis
Microarray expression analysis was performed on paren-
tal cells as well as three independent knockout mutants
and one heterozygously targeted clone. For each sample,
total RNA was extracted from three independent cell
pellets isolated at different time points. Total RNA was
extracted from cells using the RNeasy Mini Kit from
Qiagen (Valencia, CA, USA). Eluted RNA was treated
with DNaseI (NEB, Ipswich, MA, USA) before cleaning
and purifying the RNA using an RNeasy Mini Kit col-
umn (Qiagen, Valencia, CA, USA) according to the man-
ufacturers recommendations. RNA quality was assessed
by agarose gel electrophoresis and absence of contamin-
ating DNA was confirmed by PCR with primers to the
large tandem repeat DXZ4 [86]. Single stranded cDNA
was prepared using the High Capacity cDNA Reverse
Transcription Kit (Invitrogen, Grand Island, NY, USA:
Cat. No. 4368814). The cDNA was then provided to
the FSU-Nimblegen Microarray Facility for labeling,
hybridization, and washing. Probes were hybridized onto
a Human Expression 12×135K array (Roche-Nimblegen,
Indianapolis, IN, USA: 05543789001). Hybridization data
was analyzed using DNA ArrayStar version 4 (DNAS-
TAR, Madison, WI, USA). The three replicates of RPE1
were compared to one another. Transcript targets were
included if their confidence level was ≥ 95% based on a
p-value of p < 0.05. This was done for each of the mu-
tant clones. Replicate sets of each of the mutants were
compared to the RPE1 replicate set. In order to be in-
cluded, greater than two fold change in expression was
required, with a confidence level of ≥95% based on ap-value of p < 0.05. Additionally, transcript targets that
did not meet these criteria in all three of the independ-
ent mutants were excluded. Microarray expression data
has been submitted to the Gene Expression Omnibus,
and has been assigned accession number GSE47390.Quantitative RT-PCR Analysis
All qRT-PCR was performed on a CFX96 (Biorad,
Hercules, CA, USA) using EvaGreen 2X qPCR Master-
mix (ABM, Richmond, BC, Canada: Cat No. Mastermix-
S). The two-step amplification cycle began with a 10 mi-
nute incubation at 95C, followed by 40 cycles of 15 sec-
onds at 95C and 30 seconds at 60C. Fluorescence was
measured at the end of each of the 40 cycles. After-
wards, a melt curve was generated by measuring the
fluorescence after heating for 5 seconds in 0.5C incre-
ments, beginning at 65C and ending at 95C. qRT-PCR
analysis of BAZ1B used Quantitect primer assay
QT00072044 along with GAPDH assay QT01192646.
Both were obtained from Qiagen (Valencia, CA, USA).Standard RT-PCR Analysis
Standard RT-PCR was performed using OneTaq (NEB,
Ipswich, MA, USA). The cDNA samples were denatured
at 94°C for 30 seconds, amplified through 40 cycles of
30 seconds at 94°C, 30 seconds at 58°C, and 30 seconds
at 68°C, and finally held at 15°C. Details on the primers
used can be found in Additional file 7.Additional files
Additional file 1: Representative IF images of chromatin proteins
relative to the DAPI-dense blocks and the normal distribution of
H3K9me3, HP1 and SMCHD1 in parental RPE1 cells. Top panels show
representative IF images of BAZ1B −/− cells with DAPI-dense blocks,
showing the distribution of various chromatin proteins (red or green). Bot-
tom panels show the normal distribution of H3K9me3, HP1 and SMCHD1 in
parental RPE1 nuclei. The nucleus is counterstained with DAPI (blue).
Additional file 2: Movie clip of a HP1β-GFP Nucleofected BAZ1B −/−
heterochromatin block containing cell entering mitosis uninhibited.
Movie shows a cluster of three BAZ1B −/− clone D5 nuclei that are
positive for HP1β-GFP blocks. Toward the end of the movie, the middle
cell enters and exits mitosis. The movie represents a time lapse of
21 hours and 50 minutes with images captured every 5 minutes under
40X magnification. Note: The duration of the cell cycle is potentially slo-
wed due to frequent exposure to the illumination source.
Additional file 3: Movie clip of a HP1β-GFP Nucleofected BAZ1B −/−
heterochromatin block containing cell entering mitosis and giving
rise to a block-containing daughter cell. Movie shows a BAZ1B −/−
clone D5 nuclei that is positive for HP1β-GFP blocks (top left), that passes
through mitosis and gives rise to a block-containing nucleus. The blocks
appear to resolve toward the end of the movie leaving the Xi-associated
HP1β-GFP as the only remaining obvious block. For comparison, an
HP1β-GFP positive non-block containing nucleus shows only the Xi-
associated HP1β-GFP (lower central portion of movie). The movie represents
a time lapse of 62 hours and 20 minutes with images captured every 10
minutes under 60X magnification. Note: The duration of the cell cycle is
potentially slowed due to frequent exposure to the illumination source.
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http://www.biomedcentral.com/1471-2164/14/740Additional file 4: Movie clip of a HP1β-GFP Nucleofected BAZ1B −/−
heterochromatin block containing cell showing the static nature of
the block positions in the nucleus. Movie shows a BAZ1B −/− clone
D5 nuclei that is positive for HP1β-GFP blocks, that develops intense
blocks that show no obvious movement despite the mobility of the cell.
The movie represents a time lapse of 62 hours and 20 minutes with images
captured every 10 minutes under 60X magnification. Note: The duration of
the cell cycle is potentially slowed due to frequent exposure to the
illumination source.
Additional file 5: Excel file listing genes that consistently change
expression by >2-fold in BAZ1B −/− cells. File contains tabs for all data
combined, as well as gene expression for each chromosome individually.
Additional file 6: Excel file listing genes that consistently change
expression by >2-fold in BAZ1B +/− cells that are shared with
BAZ1B −/− cells.
Additional file 7: Table listing all oligonucleotides used in this study.
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